Richard Francis

As a seasoned pharmaceutical executive with over two and a half decades of experience, including leadership positions in several international corporations, Mr. Francis has a compelling track record of growing businesses in the life sciences, biologics and generic drug sectors.

Prior to joining Teva, Mr. Francis served as an operating Partner at Syncona and the Chief Executive Officer of Syncona’s portfolio companies - Purespring Therapeutics and Forcefield Therapeutics.

From 2014 to 2019, Mr. Francis served as the Chief Executive Officer of Sandoz and a member of the Novartis Executive Team. Prior to that, Mr. Francis held various leadership roles over a 13-year tenure at Biogen, including Senior Vice President of U.S. Commercial and Senior Vice President of Global Commercial Strategy. During his time at Biogen Mr. Francis led the successful launch of Tecfidera® in 2013.

Mr. Francis serves as a member of the board of directors of Mettler-Toledo International Inc. since 2016.

He holds a Bachelor of Arts in Economics from The Manchester Metropolitan University.